Long-term efficacy and safety of upadacitinib treatment in patients with Crohn´s disease: One-year results of the ongoing phase 2 CELEST open-label extension study

Geert R. D'Haens  1     Julian Panés  2     Edouard Louis  3     Qian Zhou  4     David Pugatch  4     John Liu  4     Ana P. Lacerda  4     Edward Loftus  5    
1 Amsterdam University Medical Center,Amsterdam,Netherlands
2 Hospital Clínic Barcelona, IDIBAPS, CIBERehd,Barcelona,Spain
3 CHU de Liège et Université de Liège,Liège,Belgium
4 AbbVie Inc.,Chicago,United States
5 Mayo Clinic,Rochester,

IBD I (Posters)

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing